Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man.
Prostacyclin (PGI2) is an inhibitor of platelet function in vitro. We tested the hypothesis that PGI2 is formed in biologically active concentrations at the platelet-vascular interface in man and can be pharmacologically modulated to enhance its inhibitory properties. This became feasible when we de...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
1989
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC303692/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2643628/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113895 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|